Re-live UEG Week

UEG Week edition 2023

UEG Week 2026 UEG Week 2025 UEG Week 2024 UEG Week 2023

until 08:45 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Hospital in crisis

until 09:30 · A1 PGT 3 on Gutflix

Complications of cirrhosis and liver cancer

until 09:30 · A2 PGT 5 on Gutflix

Are we ready to prevent/treat IBD with nutrition?

until 09:30 · Auditorium 15 PGT 7 on Gutflix

A journey towards an effective management of the patient with diverticular disease

until 09:30 · D3 PGT 5 on Gutflix

How do you see UC?

until 09:30 · D4 PGT 5 on Gutflix

New standards for early squamous oesophageal cancer management

more in parallel Show fewer

until 09:30 · A1 3 on Gutflix

Ways to personalise treatment in ulcerative colitis

until 09:30 · A2 3 on Gutflix

Eosinophilic oesophagitis: From diagnosis to therapy

until 09:30 · A3 5 on Gutflix

IL-23-Blockers in IBD: Part 2

until 09:30 · Auditorium 10 4 on Gutflix

Autoimmune hepatitis and colangiopathies: Update on management and outcome

until 09:30 · Auditorium 11 5 on Gutflix

What is new in GORD management: Drugs or surgery?

until 09:30 · Auditorium 12 5 on Gutflix

H. pylori: From disease pathway to therapy

until 09:30 · Auditorium 15 4 on Gutflix

Is it a diverticular disease?

until 09:30 · C1 2 on Gutflix

Disease primer: AI - the new standard in endoscopy and pathology

until 09:30 · C2 3 on Gutflix

Fungi in your gut: Friends or foes?

until 09:30 · D3 4 on Gutflix

Crash Course: Fatty liver disease

until 09:30 · D4 3 on Gutflix

What's new in 2023? Coeliac disease

until 09:30 · D5 3 on Gutflix

New aspects in neoplastic pancreatic cysts

until 09:15 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Interview with Top Abstract Awardee

more in parallel Show fewer

until 09:30 · A1 1 on Gutflix

ESGE Live Endoscopy I

until 09:30 · A2 2 on Gutflix

Implementing NAFLD management: A need for multidisciplinary teams!

until 09:30 · A3 5 on Gutflix

Hit the road JAK: Part 2

until 09:30 · Auditorium 10 5 on Gutflix

AI for GI: Glimpse in the future

until 09:30 · Auditorium 11 3 on Gutflix

Hepatobiliary endoscopy: Old procedure, new approach

until 09:30 · Auditorium 12 4 on Gutflix

What is the best recipe for EoE: PPI, steroids or monochrome?

until 09:30 · Auditorium 15 3 on Gutflix

What's new in 2023? Organ-sparing treatment for upper GI cancer

until 09:30 · C1 3 on Gutflix

Never waste a good disaster (Upper GI)

until 09:30 · C2 3 on Gutflix

Prediction of response in IBD

until 09:30 · D3 3 on Gutflix

Crash course: Endoscopic resections

until 09:30 · D4 3 on Gutflix

Barrett's oesophagus: Are we moving to a higher standard?

until 09:30 · D5 4 on Gutflix

Advances in endoscopy: Late-breaking abstracts

more in parallel Show fewer

until 10:30 · Auditorium 11 4 on Gutflix

ESGENA Opening Session: Be aware of...

until 10:30 · D3 PGT 6 on Gutflix

How does quality in endoscopy affect the prognosis of our patients?

until 10:00 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Clinical trials in IBD: Endpoint missed?

until 10:30 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | UEG Research Prize 2023: EAGLE The European Alliance for Gastrointestinal Lesions in Early Stages

until 10:30 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | UEG Journal Best Paper Award 2023: AI use in colorectal cancer surveillance of patients with Lynch syndrome

until 11:30 · A1 PGT 7 on Gutflix

Dysphagia: A bitter pill that’s hard to swallow

until 11:30 · A2 PGT 7 on Gutflix

Gastric polyps and submucosal lesions: Less is more

until 11:00 · A3 1 on Gutflix

Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH (Madrigal Pharmaceuticals)

until 11:30 · Auditorium 11 5 on Gutflix

Green endoscopy

until 11:30 · Auditorium 12 5 on Gutflix

Nutrition, tubes and trouble shooting

until 11:30 · Auditorium 15 PGT 7 on Gutflix

Getting to the bottom of benign anorectal symptoms

until 11:00 · C2 1 on Gutflix

Achieving Control in EoE: Symptoms PLUS Histologic and Endoscopic Outcomes With Dupilumab (Sanofi Regeneron)

until 11:30 · D3 PGT 8 on Gutflix

Pancreatic neuroendocrine neoplasms: Update in diagnosis and management

until 11:30 · D4 PGT 7 on Gutflix

When the gut gets stuck: The many faces of ileus

more in parallel Show fewer

until 11:00 · A1 5 on Gutflix

Breakthroughs in screening and management of colorectal lesions: Late-breaking abstracts

until 11:00 · A2 2 on Gutflix

Malignant bilio-digestive obstruction: Old tools, new ways

until 11:00 · A3 3 on Gutflix

Therapy update: Faecal microbiota transplantation

until 11:00 · Auditorium 10 3 on Gutflix

Never waste a good disaster (Hepatobiliary and pancreas)

until 11:00 · Auditorium 11 5 on Gutflix

New insights into pancreatic diseases: From inflammation to cancer

until 11:00 · Auditorium 12 4 on Gutflix

The road towards eliminating recurrence in Crohn's disease

until 11:00 · Auditorium 15 5 on Gutflix

IBD: From principles to therapy

until 11:00 · C1 2 on Gutflix

Artificial intelligence for colonoscopy: Benefit or overdiagnosis?

until 11:00 · C2 4 on Gutflix

Carcinogenesis revisited

until 11:00 · D3 3 on Gutflix

Ulcerative colitis: Navigating a crowded therapeutic landscape

until 11:00 · D4 3 on Gutflix

When the twain shall meet: What upper and lower GI experts can learn from each other

until 11:00 · D5 2 on Gutflix

Disease primer: Liver fibrosis and carcinogenesis

more in parallel Show fewer

until 11:00 · A1 1 on Gutflix

ESGE Live Endoscopy II

until 11:00 · A2 3 on Gutflix

What's new in 2023? Non-invasive tests for evaluation of NAFLD

until 11:00 · A3 5 on Gutflix

IBD aetiology

until 11:00 · Auditorium 10 4 on Gutflix

Hot topics from Pan America

until 11:00 · Auditorium 11 5 on Gutflix

Hepatobiliary and pancreatic cancer: Basic meets clinical practice

until 11:00 · Auditorium 12 5 on Gutflix

Lower GI cancer: Screening, follow-up and beyond

until 11:00 · Auditorium 15 2 on Gutflix

The gut microbiome as a driver of disease

until 11:00 · C1 3 on Gutflix

Be ready to fail to succeed! The perspective of young talents who succeeded in research

until 11:00 · C2 3 on Gutflix

Precision molecular medicine in GI cancers

until 11:00 · D3 3 on Gutflix

Medical management of Crohn's disease

until 11:00 · D4 3 on Gutflix

Advances in endoscopy: Third-space endoscopy

until 11:00 · D5 3 on Gutflix

Coeliac disease: Current dilemmas

more in parallel Show fewer

until 11:15 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Navigating the future with UEG's Equality & Diversity Plan

until 12:30 · A1 PGT 4 on Gutflix

Optimise the use of drugs in IBD

until 12:30 · A2 PGT 6 on Gutflix

Pain on the rocks: Management of painful calcifying chronic pancreatitis

until 12:30 · Auditorium 11 6 on Gutflix

New trends and developments in hygiene and infection control

until 12:30 · Auditorium 12 5 on Gutflix

New trends and developments in endoscopic techniques

until 12:30 · Auditorium 15 PGT 5 on Gutflix

Peptic ulcer disease continues to call for vigilance

until 12:30 · D3 PGT 5 on Gutflix

Best bets for biliary access: ERCP, EUS, or combination

until 12:30 · D4 PGT 6 on Gutflix

How to keep your patient with alcohol-related liver disease alive

more in parallel Show fewer

until 11:45 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Basics to understand precision medicine: Fungi in GI

until 11:45 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Interview with Late breaking abstract presenter

until 12:30 · A1 5 on Gutflix

Large lesions in the proximal colon

until 12:30 · A2 3 on Gutflix

What's new in 2023? Pancreatic and biliary cancer

until 12:30 · A3 5 on Gutflix

The new kids on the block for IBD: Part 1

until 12:30 · Auditorium 10 2 on Gutflix

Disease primer: The role of gut microenvironment in IBD and IBS

until 12:30 · Auditorium 11 5 on Gutflix

Burning questions in acute pancreatitis

until 12:30 · Auditorium 12 5 on Gutflix

GI bleeding: Prevent, detect or treat?

until 12:30 · Auditorium 15 4 on Gutflix

Outcomes in liver disease

until 12:30 · C1 3 on Gutflix

The UEG Research Prize legacy

until 12:30 · C2 3 on Gutflix

Digestive diseases: Help from the machines?

until 12:30 · D3 5 on Gutflix

40 years of H. pylori : Back to the future

until 12:30 · D4 3 on Gutflix

Gastric cancer: Timing is key

until 12:30 · D5 4 on Gutflix

Mistakes in ...: Hepatobiliary and pancreas

more in parallel Show fewer

until 12:30 · A1 1 on Gutflix

ESGE Live Endoscopy III

until 12:30 · A2 3 on Gutflix

Autoimmunity in HPB

until 12:30 · A3 5 on Gutflix

Sequential therapies in IBD: Raising the bar

until 12:30 · Auditorium 10 4 on Gutflix

From guidelines to clinical practice: Pancreatic exocrine insufficiency

until 12:30 · Auditorium 11 5 on Gutflix

Precision medicine of tomorrow in GI cancer

until 12:30 · Auditorium 12 4 on Gutflix

Mechanisms and treatment of steatotic liver

until 12:30 · Auditorium 15 3 on Gutflix

Therapy update: Gastroparesis

until 12:30 · C1 3 on Gutflix

Crash Course: Upper GI bleeding

until 12:30 · C2 3 on Gutflix

Organoids in GI

until 12:30 · D3 5 on Gutflix

Therapy update: The integrated approach to optimising care of the patient with IBD

until 12:30 · D4 3 on Gutflix

Advances in endoscopy: Biliopancreatic endoscopy

until 12:30 · D5 5 on Gutflix

The various impacts of diet: From IBD to liver

more in parallel Show fewer

until 13:00 · A1 1 on Gutflix

Achieving control in Crohn's disease: today and tomorrow (Takeda)

until 13:00 · A3 1 on Gutflix

Modernizing Ulcerative Colitis Treatment with S1P Receptor Modulators (Bristol Myers Squibb)

until 13:00 · Auditorium 11 3 on Gutflix

Sedation

until 13:00 · Auditorium 12 3 on Gutflix

Hygiene and infection control

until 13:00 · Auditorium 15 1 on Gutflix

It takes two to tango in UC: let’s get in sync with our patients (Pfizer Inc.)

until 13:00 · C2 1 on Gutflix

Bringing light into new treatment targets: the role of histology and molecular healing in UC (Eli Lilly and Company)

until 13:00 · D5 1 on Gutflix

Blazing the trail - From IL-12/23 to IL-23 and beyond (Janssen)

more in parallel Show fewer

until 14:00 · A2 1 on Gutflix

Gathering intelligence to improve long-term outcomes in ulcerative colitis: new evidence (Takeda)

until 14:00 · A3 1 on Gutflix

Complex IBD patient

until 14:00 · Auditorium 12 1 on Gutflix

Rare HPB disease

until 14:00 · Auditorium 15 1 on Gutflix

The real-world experience: Navigating the ocean of JAKi evidence to help improve outcomes for patients with UC (Pfizer Inc.)

until 14:00 · C2 1 on Gutflix

Dyspepsia or reflux

until 14:00 · D4 1 on Gutflix

JAK inhibition and individualised care: comprehensive management in UC (Galapagos)

until 14:00 · D5 1 on Gutflix

Bringing light to patient centric goals in UC: the LUCENT results (Eli Lilly and Company)

more in parallel Show fewer

until 14:00 · A3 1 on Gutflix

Palliation in gastric cancer

until 14:00 · Auditorium 12 1 on Gutflix

Spontaneous bacterial peritonitis

until 14:00 · C2 1 on Gutflix

Metastasised colorectal cancer

until 14:00 · D5 1 on Gutflix

Untangling the Knots: Exploring the Dynamics of Complex Relationships between Ulcerative Colitis and Clostridioides difficile Infections (Tillotts Pharma AG)

more in parallel Show fewer

until 15:00 · A1 PGT 4 on Gutflix

Disease activity in IBD: When and how hard to look for it?

until 15:00 · A2 PGT 5 on Gutflix

Autoimmune pancreatitis: The story continues

until 15:00 · Auditorium 11 6 on Gutflix

Liver nurses: Advanced roles

until 15:00 · Auditorium 12 6 on Gutflix

Free papers I: Management and patient safety

until 15:00 · Auditorium 15 PGT 5 on Gutflix

Refractory constipation: Is there light at the end of the tunnel?

until 15:00 · D3 PGT 4 on Gutflix

The experts' guide to Barrett's oesophagus

until 15:00 · D4 PGT 4 on Gutflix

Safe feeding

more in parallel Show fewer

until 15:00 · Auditorium 11 4 on Gutflix

My worst case and what I learnt from it

until 15:00 · Auditorium 12 4 on Gutflix

Education and management

until 15:00 · D3 8 on Gutflix

Opening Plenary

until 14:15 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Advances in endoscopy: How small do we want to get with imaging?

until 14:45 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Burnout in European Gastroenterology - A call to action

until 15:30 · A1 3 on Gutflix

Early colorectal cancer

until 15:30 · A2 3 on Gutflix

Management of end stage liver disease

until 15:30 · A3 5 on Gutflix

The new kids on the block in IBD: Part 2

until 15:30 · Auditorium 10 3 on Gutflix

Non-IBD related colitis

until 15:30 · Auditorium 11 5 on Gutflix

Training and life of a young gastroenterologist

until 15:30 · Auditorium 12 5 on Gutflix

Gut microbiome: From bench to bedside

until 15:30 · Auditorium 15 3 on Gutflix

Therapy update: Extra oesophageal symptoms

until 15:30 · C1 3 on Gutflix

How to manage the key symptoms in functional bowel disorders?

until 15:30 · C2 3 on Gutflix

Mechanisms of fibrogenesis: A unifying theme in HPB?

until 15:30 · D3 5 on Gutflix

Hit the road JAK: Part 1

until 15:30 · D4 4 on Gutflix

Unsolved issues in IBD outcome

until 15:30 · D5 3 on Gutflix

Precision medicine in pancreatic cancer

more in parallel Show fewer

until 15:30 · A1 5 on Gutflix

AI and machine learning in gastroenterology: Late-breaking abstracts

until 15:30 · A2 3 on Gutflix

Therapy update: Viral hepatitis

until 15:30 · A3 5 on Gutflix

The switch game: Optimal treatment modalities in IBD

until 15:30 · Auditorium 10 5 on Gutflix

Improved monitoring for disease activity in IBD

until 15:30 · Auditorium 11 4 on Gutflix

GI cancer: Screening or prevention

until 15:30 · Auditorium 12 5 on Gutflix

Disorders of gut-brain interactions: New tricks for old dogs

until 15:30 · Auditorium 15 3 on Gutflix

Dietary advice for functional gastrointestinal disorders

until 15:30 · C1 4 on Gutflix

Mistakes in ...: Lower GI

until 15:30 · C2 3 on Gutflix

What's new in oncology in 2023?

until 15:30 · D3 2 on Gutflix

New insights in perianal Crohn's disease

until 15:30 · D4 3 on Gutflix

Advances in endoscopy: Quality in colonoscopy

until 15:30 · D5 2 on Gutflix

Bile duct disease revisited in 2023

more in parallel Show fewer

until 17:00 · A1 PGT 5 on Gutflix

Fulminant hepatitis, liver failure and liver transplantation

until 17:00 · A2 PGT 10 on Gutflix

Advanced colorectal cancer

until 17:00 · Auditorium 11 4 on Gutflix

IBD nurses: All around the gut

until 17:00 · Auditorium 12 5 on Gutflix

Free papers II: Patient care and assistance

until 17:00 · Auditorium 15 PGT 6 on Gutflix

Diagnosis and management of small bowel tumours: Looking for a needle in a haystack?

until 17:00 · D3 PGT 7 on Gutflix

Severe acute pancreatitis: Management and complications

until 17:00 · D4 PGT 6 on Gutflix

Unexplained weight loss: Is it a gastrointestinal disorder, an eating disorder, or both?

more in parallel Show fewer

until 16:30 · A1 3 on Gutflix

From guidelines to clinical practice: Chronic nausea and vomiting

until 16:30 · A2 3 on Gutflix

Complications of the portal vein: The portal vein thrombosis board

until 16:30 · A3 5 on Gutflix

AI in lower GI endoscopy

until 16:30 · Auditorium 10 4 on Gutflix

Achalasia: Is POEM the ultimate solution?

until 16:30 · Auditorium 11 5 on Gutflix

Standardising ESD for upper GI

until 16:30 · Auditorium 12 5 on Gutflix

Molecular roadway to upper GI cancer

until 16:30 · Auditorium 15 7 on Gutflix

Video Case Session

until 16:30 · C1 3 on Gutflix

Pain in IBS and IBD

until 16:30 · C2 3 on Gutflix

Microbiome at GI interfaces

until 16:30 · D3 3 on Gutflix

What's new in IBD in 2023?

until 16:30 · D4 3 on Gutflix

Colorectal cancer screening and surveillance: How far should we go?

until 16:30 · D5 3 on Gutflix

Update on chronic pancreatitis: How to diagnose and how to treat?

more in parallel Show fewer

until 17:00 · A1 2 on Gutflix

Reproductive health in IBD patients

until 17:00 · A2 3 on Gutflix

Therapy update: Hepatocellular carcinoma

until 17:00 · A3 5 on Gutflix

Update on pathophysiology and management in cirrhosis

until 17:00 · Auditorium 10 3 on Gutflix

Small bowel tumours

until 17:00 · Auditorium 11 5 on Gutflix

Cystic neoplasia at the pancreas: From EUS to molecular mechanisms

until 17:00 · Auditorium 12 5 on Gutflix

Big steps for coeliac and short bowel

until 17:00 · Auditorium 15 3 on Gutflix

Junctional gastro-oesophageal cancer

until 17:00 · C1 5 on Gutflix

Advanced imaging for advanced colorectal lesion

until 17:00 · C2 5 on Gutflix

Traffic control in IBD

until 17:00 · D3 3 on Gutflix

Microbiota in clinical practice: What is new and what is true?

until 17:00 · D4 3 on Gutflix

Rising Stars from Europe and Japan

until 17:00 · D5 3 on Gutflix

Advancing HPB endoscopy

more in parallel Show fewer

until 18:00 · A1 5 on Gutflix

Breakthroughs in IBD treatment and outcomes: Late-breaking abstracts

until 18:00 · A2 5 on Gutflix

Mistakes in ...: Upper GI

until 18:00 · A3 5 on Gutflix

IL-23-Blockers in IBD: Part 1

until 18:00 · Auditorium 10 3 on Gutflix

From guidelines to clinical practice: Malnutrition

until 18:00 · Auditorium 11 5 on Gutflix

Molecular and transitional aspects of PDHC

until 18:00 · Auditorium 12 5 on Gutflix

Progress in liver disease biomarkers

until 18:00 · Auditorium 15 5 on Gutflix

Advanced endoscopy for early CRC: The final answer?

until 18:00 · C1 3 on Gutflix

Never waste a good disaster (Lower GI)

until 18:00 · C2 3 on Gutflix

Microbiome-based precision medicine

until 18:00 · D3 4 on Gutflix

Management of acute pancreatitis

until 18:00 · D4 5 on Gutflix

Best of DDW

until 18:00 · D5 8 on Gutflix

Best of hepatology in UEG Journal

more in parallel Show fewer

until 18:00 · UEG Week+ Studio 1 on Gutflix

UEG Week+ | Policy dialogue WHO with UEG

until 18:30 · Auditorium 11 1 on Gutflix

Nurses at the Forefront of IBD Care (Bristol Myers Squibb)

until 18:30 · A1 1 on Gutflix

Revolutionizing the treatment landscape in Crohn’s disease: How IL-23 and JAK inhibitors are changing the rhythm (AbbVie)

until 18:30 · D5 1 on Gutflix

Expanding Horizons in EoE: The Journey to Long-Term Disease Control (Sanofi Regeneron)

until 19:30 · Auditorium 10 1 on Gutflix

Refining the Journey in the Treatment of IBD with Subcutaneous Infliximab (Celltrion Healthcare)

until 19:30 · Auditorium 15 1 on Gutflix

Liver in the room: Big enough to challenge and drive the change in MASH* management. *Formerly known as NASH (Novo Nordisk A/S)